Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ORTHO CLINICAL DIAGNOSTICS HOLDINGS PLC

(OCDX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Ortho Clinical Diagnostics to Participate in the 4th Annual Evercore ISI HealthCONx Conference

11/23/2021 | 08:01am EST

RARITAN, N.J., Nov. 23, 2021 (GLOBE NEWSWIRE) --  Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics (IVD) companies, today announced that members of its management team are scheduled to participate in the 4th Annual Evercore ISI HealthCONx Conference on Tuesday, November 30, 2021, with a fireside chat scheduled for 3:30pm ET.

Interested parties can access a live webcast and replay of the fireside chat on the “Investors” page of the company’s website at https://ir.orthoclinicaldiagnostics.com/, under the “Events” section of the page.

About Ortho Clinical Diagnostics

Ortho Clinical Diagnostics (Nasdaq: OCDX) is one of the world’s largest pure-play in vitro diagnostics (IVD) companies dedicated to transforming patient care.

More than 800,000 patients across the world are impacted by Ortho’s tests each day. Because Every Test Is A LifeTM, Ortho provides hospitals, hospital networks, clinical laboratories and blood banks around the world with innovative technology and tools to ensure test results are fast, accurate and reliable. Ortho's customized solutions enhance clinical outcomes, improve efficiency, overcome lab staffing challenges and reduce costs.

From launching the first product to determine Rh+ or Rh- blood type, developing the world’s first tests for the detection of antibodies against HIV and hepatitis C, introducing patented dry-slide technology, and marketing the first U.S. Food and Drug Administration-authorized high-volume antibody and antigen tests for COVID-19, Ortho has been a pioneering leader in the IVD space for over 80 years.

The company is powered by Ortho Care® Service and Support, an award-winning, holistic program that ensures best-in-class technical, field, and remote service and inventory support to laboratories in more than 130 countries and territories around the globe.

For more information, visit Ortho’s social media channels: LinkedIn, Twitter, Facebook and YouTube. 

Investors:

IR@orthoclinicaldiagnostics.com

Media:

media@orthoclinicaldiagnostics.com


Source: Ortho-Clinical Diagnostics, Inc

2021 GlobeNewswire, Inc., source Press Releases

All news about ORTHO CLINICAL DIAGNOSTICS HOLDINGS PLC
01/18ORTHO CLINICAL DIAGNOSTICS : CONFIDENTIAL - Retention/Loyalty Bonus Opportunity & Agreemen..
PU
01/18ORTHO CLINICAL DIAGNOSTICS HOLDINGS : Change in Directors or Principal Officers, Financia..
AQ
01/11ORTHO CLINICAL DIAGNOSTICS HOLDINGS : Regulation FD Disclosure, Financial Statements and ..
AQ
01/07INSIDER SELL : Ortho Clinical Diagnostics Holdings
MT
01/06ORTHO CLINICAL DIAGNOSTICS : Announces Preliminary Financial Results for Fourth Quarter an..
PU
01/06Ortho Clinical Diagnostics Holdings Reports Preliminary Q4 Revenue Range in Line With E..
MT
01/06Ortho Clinical Diagnostics Announces Preliminary Financial Results for Fourth Quarter a..
GL
01/06Ortho Clinical Diagnostics Holdings plc Announces Preliminary Unaudited Revenue Results..
CI
01/06Ortho Clinical Diagnostics Holdings plc Provides Earnings Guidance for the Fourth Quart..
CI
01/03Ortho Clinical Diagnostics to Participate in the 40th Annual J.P. Morgan Healthcare Con..
AQ
More news
Analyst Recommendations on ORTHO CLINICAL DIAGNOSTICS HOLDINGS PLC
More recommendations
Financials (USD)
Sales 2021 2 041 M - -
Net income 2021 -45,7 M - -
Net Debt 2021 2 020 M - -
P/E ratio 2021 -101x
Yield 2021 -
Capitalization 4 447 M 4 447 M -
EV / Sales 2021 3,17x
EV / Sales 2022 2,95x
Nbr of Employees 4 700
Free-Float -
Chart ORTHO CLINICAL DIAGNOSTICS HOLDINGS PLC
Duration : Period :
Ortho Clinical Diagnostics Holdings plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ORTHO CLINICAL DIAGNOSTICS HOLDINGS PLC
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 5
Last Close Price 18,75 $
Average target price 24,27 $
Spread / Average Target 29,5%
EPS Revisions
Managers and Directors
Christopher Michael Smith Chief Executive Officer & Director
Joseph Michael Busky Chief Financial Officer
Marwan Fathallah Head-Compliance, Regulatory & Clinical
Karen H. Bechtel Independent Director
Allan M. Holt Independent Director
Sector and Competitors